Nanoplastics impair antibiotic effectiveness and promote resistance

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) Cal­i­brate, the weight loss start­up that rose

Dara­prim, the an­ti-malar­i­al and an­ti-par­a­sitic at the heart of “Phar­ma Bro” Mar­tin Shkre­li’s price-goug­ing no­to­ri­ety, is chang­ing hands once again. Vy­era Phar­ma­ceu­ti­cals — for­mer­ly known

Rock­et Phar­ma is get­ting ready to light up na­tion­al land­marks on Thurs­day as part of its an­nu­al rare dis­ease aware­ness ef­fort, but this year the